Literature DB >> 67910

Production of specific macrophage activating factor by lymphocytes from tumor-bearing mice.

M L Kripke, M B Budmen, I J Fidler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 67910     DOI： 10.1016/0008-8749(77)90077-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  4 in total

Review 1.  Macrophages and cancer.

Authors:  P W Whitworth; C C Pak; J Esgro; E S Kleinerman; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

2.  Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.

Authors:  I Sugawara; K C Lee; M Wong
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.

Authors:  L P Seung; D A Rowley; P Dubey; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

4.  Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.

Authors:  I J Fidler; S Sone; W E Fogler; Z L Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.